Altos Labs
Restoring cell health and resilience
- Headquarters
- San Francisco, California
- Employees
- 501–1000
- Founded
- 2021
- Business Model
- B2B
- Website
- altoslabs.com
- Total Funding
- $3.0B
- Last Round
- Series AJan 2022
- Rounds
- 1
About
Altos Labs is a biotechnology company pursuing cellular rejuvenation programming to restore cell health and resilience, with the aim of reversing disease, injury, and the disabilities that can occur throughout life. Building on Nobel Prize-winning research in cellular reprogramming, Altos operates research institutes in the San Francisco Bay Area, San Diego, and Cambridge (UK). It launched in 2022 with roughly $3 billion in initial funding from investors including ARCH Venture Partners, Jeff Bezos, and Yuri Milner, making it one of the best-funded biotech startups ever.
Summary
Altos Labs is a Life Sciences company based in San Francisco, United States, founded in 2021. It has raised $3.0B in total across 1 round, most recently a Series A round in Jan 2022.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jan 2022
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company
Specialty pharmaceutical company
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...